PuraPharm Corporation Limited announced that it has entered into a share purchase agreement with existing investor, Enm Holdings Ltd for a private placement of 50,229 shares at HKD 796.3527 per share for gross proceeds of HKD 40,000,000 on December 31, 2014. The shares to be issued heave par value of HKD 1 per share. The investor will acquire 4.33% stake in the company through this transaction.

The company will purchase shares from Fullgold Development Limited for gross proceeds of HKD 10,000,000 for 1.33% stake and will purchase new shares for gross proceeds of HKD 30,000,000 for 4% stake. After the completion of the transaction, the investor will hold 10.13% stake in the company consisting 95,475 ordinary shares. The transaction is expected to close on or before December 31, 2014.

The company reported net assets of HKD 53,841,000 and unaudited consolidated net profit before taxation of HKD 22,558,000 for the year ending December 31, 2013.